Moolmuang, B., & Ruchirawat, M. (2021). The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. J Pharm Pharmacol, 73(1), 40-51. doi:10.1093/jpp/rgaa050

01 Mar 2021
0

Moolmuang, B., & Ruchirawat, M. (2021). The antiproliferative effects of ataxia-telangiectasia mutated and ATM- and Rad3-related inhibitions and their enhancements with the cytotoxicity of DNA damaging agents in cholangiocarcinoma cells. J Pharm Pharmacol, 73(1), 40-51. doi:10.1093/jpp/rgaa050

Tags

Share this

Related Posts

Bacillus subtilis SSE4 produces subtulene A, a new lipopeptide antibiotic possessing an unusual C15 unsaturated beta-amino acid. Thasana N, Prapagdee B, Rangkadilok N, Sallabhan R, Aye SL, Ruchirawat S, Loprasert S FEBS Lett 2010; 584: 3209-14.
Andrographis paniculata dissolution investigation and pharmacokinetic studies of four major active diterpeniods after multiple oral dose. Pholphana N, Panomvana D, Rangkadilok N, Suriyo T, Puranajoti P, Ungtrakul T, Pongpun W, Thaeopattha S, Songvut P, Satayavivad J. J Ethnopharmacol 2016; 194: 513-21.

Recent Posts